Search results
Mankind Pharma Block Deal: Capital Group affiliate Hema CIPEF likely to sell 0.9% stake - CNBC TV18
CNBC TV18· 8 hours agoShares of Mankind Pharma Ltd ended at ₹2,105.45, up by ₹44.80, or 2.17% on the BSE.
Stakes High For Himachal Pradesh CM Sukhu as Wife Kamlesh Debuts With Dehra Bypoll - News18
News18· 18 hours agoThe stakes are high for Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu with his wife in the...
Bulk deals: Kotak Mahindra Mutual Fund buys 1.75% stake in Vijaya Diagnostic Centre
CNBC Awaaz· 10 hours agoAviator Global Investment Fund sold a 0.71 percent stake in Rama Steel Tubes for an average price of...
Reports of 51% stake sale "factually incorrect", says Yes Bank; shares climb
CNBC Awaaz· 20 hours agoYes Bank shares climbed two percent in the morning trade session on July 9 after the lender...
Radhakishan Damani raises stake in this cigarette stock during Q1, cuts holding in Blue Dart - The...
The Economic Times· 1 day agoAce investor Radhakishan Damani has raised stake in VST Industries during the June quarter, while...
Yes Bank clarifies on ‘stake sale’ report, calls it ‘factually incorrect’; stock up 2.5% | Stock...
Livemint· 20 hours agoYes Bank clarifies on ‘stake sale’ report, calls it ‘factually incorrect’
Joe Biden Braces For High-Stakes NATO Summit Amid Political Scrutiny - News18
News18· 7 hours agoAmid political scrutiny after debate debacle, US President Joe Biden braces for high-stakes NATO...
Multibagger stock Nile hits lifetime high after Dolly Khanna’s stake buying news | Stock Market News
Livemint· 19 hours agoAccording to the shareholding pattern of Nile Ltd for the April to June 2024 quarter, Dolly Khanna...
Punjab CM’s mettle at stake in Jalandhar (West) bypoll
Daiji World· 12 hours agoThe Jalandhar West (reserved) Assembly segment is a hub of Dalits in Punjab’s Doaba region. While...
Dubious drug trials | Why the reputation of 'the Pharmacy of the World' is at stake now - CNBC TV18
CNBC TV18· 16 hours agoThe rising cases of dubious drug trials in India also raise serious questions about the monitoring...